Literature DB >> 24078317

Preventing type 2 diabetes, CVD, and mortality: surgical versus non-surgical weight loss strategies.

D J Pournaras1, C W le Roux.   

Abstract

The burden of type 2 diabetes is increasing. The prevention of the disease, improvement of metabolic control, and more importantly reduction in mortality remain a challenge for primary care doctors, diabetologists, researchers and policymakers. In this article, the available literature is reviewed with a focus on recent developments. Comparison between medical and surgical interventions is performed using mainly head-to-head trials where possible. Weight loss surgery is effective for glycaemic control. The need for level 1 data with hard end points such as cardiovascular risk and mortality is highlighted, and the prospect of the combination of existing therapy options is emphasized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078317     DOI: 10.1007/s11883-013-0367-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  33 in total

Review 1.  Potential of surgery for curing type 2 diabetes mellitus.

Authors:  Francesco Rubino; Michel Gagner
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 2.  Impact of gastrointestinal surgery on cardiometabolic risk.

Authors:  Fady Moustarah; Audrée Gilbert; Jean-Pierre Després; André Tchernof
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

Review 3.  Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.

Authors:  L Sjöström
Journal:  J Intern Med       Date:  2013-02-08       Impact factor: 8.989

4.  Health benefits of gastric bypass surgery after 6 years.

Authors:  Ted D Adams; Lance E Davidson; Sheldon E Litwin; Ronette L Kolotkin; Michael J LaMonte; Robert C Pendleton; Michael B Strong; Russell Vinik; Nathan A Wanner; Paul N Hopkins; Richard E Gress; James M Walker; Tom V Cloward; R Tom Nuttall; Ahmad Hammoud; Jessica L J Greenwood; Ross D Crosby; Rodrick McKinlay; Steven C Simper; Sherman C Smith; Steven C Hunt
Journal:  JAMA       Date:  2012-09-19       Impact factor: 56.272

5.  Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).

Authors:  J Lindström; M Peltonen; J G Eriksson; P Ilanne-Parikka; S Aunola; S Keinänen-Kiukaanniemi; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  2012-10-24       Impact factor: 10.122

6.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

7.  How do we define cure of diabetes?

Authors:  John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

8.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

9.  Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders.

Authors:  D J Pournaras; E T Aasheim; T T Søvik; R Andrews; D Mahon; R Welbourn; T Olbers; C W le Roux
Journal:  Br J Surg       Date:  2011-10-21       Impact factor: 6.939

10.  Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes.

Authors:  Alexander D Miras; Ling Ling Chuah; Gerassimos Lascaratos; Sana Faruq; Ajay A Mohite; Priya R Shah; Mahi Gill; Sabrina N Jackson; Desmond G Johnston; Torsten Olbers; Carel W le Roux
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more
  1 in total

1.  Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; María J Gil; Fernando Rotellar; Secundino Fernández; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Surg Endosc       Date:  2014-03-13       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.